MAP3K5 and Cognitive impairment: Pei et al. [52] demonstrated that QC significantly reduced cognitive impairments in the MWM test, reducing apoptosis and neuronal death by inhibiting the ASK1/JNK3/caspase-3 pathway and inducing the Akt signaling pathway.